The store will not work correctly when cookies are disabled.
N-(4-(5-cyano-1-methyl-1H-pyrrol-2-yl)-3,5-difluorophenyl)ethanesulfonamide
ID: ALA2203836
PubChem CID: 16051364
Max Phase: Preclinical
Molecular Formula: C14H13F2N3O2S
Molecular Weight: 325.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCS(=O)(=O)Nc1cc(F)c(-c2ccc(C#N)n2C)c(F)c1
Standard InChI: InChI=1S/C14H13F2N3O2S/c1-3-22(20,21)18-9-6-11(15)14(12(16)7-9)13-5-4-10(8-17)19(13)2/h4-7,18H,3H2,1-2H3
Standard InChI Key: YSIQBSLZQKNAIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
17.7966 -14.5526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2093 -15.2625 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.6177 -14.5501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3808 -14.4494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3796 -15.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0877 -15.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7973 -15.2685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7945 -14.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0859 -14.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5057 -15.6759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6774 -14.0414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6946 -13.2244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9229 -12.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4287 -13.6064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8950 -14.2774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6262 -15.0491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6150 -13.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7980 -13.5700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9211 -15.6737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6289 -15.2653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0834 -13.2233 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.6716 -15.6770 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
4 11 1 0
15 16 1 0
17 18 3 0
14 17 1 0
10 2 1 0
2 19 1 0
19 20 1 0
9 21 1 0
5 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.34 | Molecular Weight (Monoisotopic): 325.0697 | AlogP: 2.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 74.89 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.75 | CX Basic pKa: ┄ | CX LogP: 1.79 | CX LogD: 1.77 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.94 | Np Likeness Score: -1.64 |
References
1. McComas C, Cohen J, Huselton C, Marella M, Melenski E, Mugford C, Slayden O, Winneker R, Wrobel J, Yudt MR, Fensome A.. (2012) Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides., 22 (23): [PMID:23079530] [10.1016/j.bmcl.2012.09.077] |